Inhibition by arsenite of anticancer drug cis-diamminedichloroplatinum(II) induced DNA repair and drug resistance in HeLa cells
- 15 May 1996
- journal article
- Published by Elsevier in Environmental Toxicology and Pharmacology
- Vol. 1 (3) , 199-205
- https://doi.org/10.1016/1382-6689(96)00010-5
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Resistance to arsenic compounds in microorganismsFEMS Microbiology Reviews, 1994
- Use of a monoclonal antibody to detect DNA damage caused by the anticancer drug cis‐diamminedichloroplatinum (II) in vivo and in vitroFEBS Letters, 1994
- Apparent alterations in the early stage of excision repair of UV-induced DNA damages in a HeLa mutant cell line that is resistant to genotoxic stressesMutation Research Letters, 1993
- Damage-recognition proteins as a potential indicator of DNA-damage-mediated sensitivity or resistance of human cells to ultraviolet radiationBiochemical Journal, 1992
- Identification of inducible damage-recognition proteins that are overexpressed in HeLa cells resistant to cis-diamminedichloroplatinum (II)Biochemical Journal, 1991
- Cross-resistance to UV radiation of a cisplatin-resistant human cell line: overexpression of cellular factors that recognize UV-modified DNA.Molecular and Cellular Biology, 1991
- Stress protein synthesis in human keratinocytes treated with sodium arsenite, phenyldichloroarsine, and nitrogen mustard*1Fundamental and Applied Toxicology, 1990
- DNA amplification in arsenite-resistant LeishmaniaExperimental Cell Research, 1989
- Xeroderma Pigmentosum Group E Cells Lack a Nuclear Factor That Binds to Damaged DNAScience, 1988
- Electroporation for the efficient transfection of mammalian cells with DNANucleic Acids Research, 1987